A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.

Mounjaro (tirzepatide) is a prescription drug used ... Whether you have health insurance or not, cost may be a factor when you’re considering Mounjaro. What you’ll pay for Mounjaro may depend ...

Financial analysis of Pfizer Inc. stock ahead of its earnings release. PFE faces significant headwinds from patent expiries, click for my updated look at the stock.

FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Mounjaro (tirzepatide) is prescribed to help manage ... To learn more about Mounjaro, including its uses, dosage, and cost, refer to this Mounjaro overview article. Mounjaro has a boxed warning.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

Obesity programs: <li /> Phase 2 BMT-801 clinical study with MC4R agonist bremelanotide plus GLP-1/GIP dual agonist tirzepatide ...

Developed initially to manage diabetes, glucagon-like peptide-1 (GLP-1) receptor agonists have skyrocketed in popularity ...

LEXX READ THE FULL LEXX RESEARCH REPORT Lexaria Bioscience Corporation (NASDAQ:LEXX) reported fiscal first quarter 2025 results along with program updates, progress in its GLP-1 trials, a capital ...